GEISTWERT Rechtsanwälte Lawyers Avvocati

https-www.unifiedpatentcourt.org-en-node-162177-ef47f7e85b64

Samsung Bioepis NL B.V. v. Alexion Pharmaceuticals, Inc.

Datum
2026-02-18
Kammer
Luxembourg (LU)
Verfahrensart
Application Rop 265
Sprache
EN

Metadaten

Fall-IDhttps-www.unifiedpatentcourt.org-en-node-162177-ef47f7e85b64
Aktenzeichen
Registerzeichen
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

DECISION of the Court of Appeal of the Unified Patent Court issued on 18 February 2026 concerning a withdrawal pursuant to R. 265.1 RoP APPELLANT (AND DEFENDANT BEFORE THE COURT OF FIRST INSTANCE) Samsung Bioepis NL B.V., Delft, The Netherlands (hereinafter referred to as: “Samsung”) represented by Dr. Peter Meyer, attorney at law, Simmons & Simmons LLP , Munich, Germany RESPONDENT (AND CLAIMANT BEFORE THE COURT OF FIRST INSTANCE) Alexion Pharmaceuticals, Inc., Boston, United States (hereinafter referred to as: “Alexion”) represented by Elena Hennecke, attorney at law, Freshfields Bruckhaus Deringer Rechtsanwälte Steuerberater PartG mbB, Düsseldorf, Germany PATENT AT ISSUE EP 3 167 888 LANGUAGE OF THE PROCEEDINGS English DECIDING JUDGE Rian Kalden, legally qualified judge and standing judge U ...